The Deadline Approaches: Kyverna Therapeutics Investors Urged to Act

The Law Offices of Frank R. Cruz remind investors that February 7, 2025 is the key deadline for those wishing to become lead plaintiffs in a securities fraud class action lawsuit against Kyverna Therapeutics, Inc. (“Kyverna”) KYTX. This action is on behalf of investors who purchased common stock connected to the Company’s February 2024 initial public offering (IPO).

DID YOU LOSE MONEY INVESTING IN KYVERNA THERAPEUTICS, INC. (KYTX)? CLICK HERE TO JOIN THE LAWSUIT.

Overview of the Events

Kyverna completed its IPO on February 8, 2024, selling 14.5 million shares at $22.00 each. However, on June 14, 2024, the Company disclosed troubling information about its lupus nephritis drug, KYV-101, revealing negative results from a clinical trial that contradicted their earlier claims of patient improvement.

Since the IPO, investors have experienced substantial losses. Currently, Kyverna’s stock is trading as low as $3.92 per share, a decline of over 82% from the IPO price.

Details of the Legal Action

The class-action lawsuit alleges that throughout the Class Period, Kyverna’s Defendants made misleading statements and failed to reveal critical adverse information about the Company’s business and prospects. Key omissions include: (1) adverse data concerning one of its trials; (2) the risk associated with concealing this data; and (3) that the positive statements regarding the Company’s prospects lacked a solid basis.

Important Participation Date

For any investors who purchased Kyverna stock linked to the IPO, the deadline to apply as a lead plaintiff in this lawsuit is February 7, 2025.

How to Get Involved or Learn More:

If you want more information about this class action or have questions about your rights in relation to this lawsuit, please reach out to:

Frank R. Cruz
The Law Offices of Frank R. Cruz,
2121 Avenue of the Stars, Suite 800,
Century City, California 90067
Email: [email protected]
Phone: 310-914-5007
Website: www.frankcruzlaw.com
Follow us for updates on Twitter: twitter.com/FRC_LAW

If you contact us by email, please include your address, phone number, and the number of shares you purchased.

To participate in the class action, no immediate action is required. You may choose your own counsel or remain an absent member of the class. Please note that this announcement may be classified as Attorney Advertising in certain jurisdictions according to applicable laws and ethical standards.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250205431517/en/

The Law Offices of Frank R. Cruz, Los Angeles
Frank R. Cruz, 310-914-5007
[email protected]
www.frankcruzlaw.com